340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

HRSA Strikes Three Off List of Drugmakers Denying 340B Pricing on Orphan Meds

CMS wants states to know Medicaid rebates are available on non-340B-discounted orphan products 

April 2, 2015—The Health Resources and Services Administration has removed three drugmakers from its list of those that do not provide 340B pricing on orphan drugs to rural and cancer hospitals. … [Read more...]

Biosimilars Treated Like Brand-Name Drugs for 340B Discounts

CMS decision about classification for rebates carries over into 340B program 

April 1, 2015—The Centers for Medicare & Medicaid Services announced a policy decision about Medicaid drug rebates this week that will result in safety-net healthcare providers getting the same 340B discount percentage on biosimilar medicines as they receive on brand-name drugs. … [Read more...]

HHS Asks Court Again to Dismiss 340B Orphan Drug Exclusion Lawsuit

Reiterates arguments made in January motion for dismissal 

March 24, 2015—The Department of Health and Human Services has again urged a federal district judge to dismiss the drug industry’s lawsuit against the 340B orphan drug exclusion interpretive rule, saying the industry's claim that the rule violates the Administrative Procedures Act has no merit. … [Read more...]

House Subcommittee Holds Hearing on 340B

Members express support but want more clarity and transparency 

March 24, 2015—Members of a House health subcommittee expressed strong support for the 340B program during a hearing today, with some stating more should be done to clarify program requirements and enhance program transparency. … [Read more...]

House 340B Hearing Rescheduled for March 24

HRSA, GAO, and OIG are slated to testify 

March 17, 2015—The House Energy & Commerce Health Subcommittee has rescheduled a hearing on the 340B program for March 24, according to a notation on the subcommittee's home page. The session was originally slated for March 5 but postponed due to a snowstorm. … [Read more...]

HRSA’s Wakefield Elevated to Number Two Post at HHS

Jim Macrae, who has run FQHC's parent bureau, will run HRSA on acting basis 

March 12, 2015—Mary Wakefield, who has led the Heath Resources and Services Administration since 2009, was today named Acting Deputy Secretary of Health and Human Services. … [Read more...]

Prescription Drug Spending Jumped 13.1% Last Year, Study Finds

Hepatitis C drugs helped fuel the biggest year-to-year increase since 2003 

March 11, 2015—Prescription drug spending skyrocketed in 2014, rising 13.1 percent over 2013 for all drugs – the highest rate in a decade – and a record-setting 30.9 percent for specialty drugs, according to a new report by pharmacy benefit management company Express Scripts. … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health